Cardiovascular Risk Factor Management in the Prevention of by P. Amarenco

By P. Amarenco

Complement factor: Cerebrovascular ailments 2003, Vol. sixteen, Suppl. three

Show description

Read or Download Cardiovascular Risk Factor Management in the Prevention of Stroke: Satellite Symposium Held on the Occasion of the 11th European Stroke Conference, ... 2002: Proceedings (CEREBROVASCULAR DISEASES) PDF

Best neurology books

Noise and the Brain: Experience Dependent Developmental and Adult Plasticity

In our industrialized global, we're surrounded through occupational, leisure, and environmental noise. Very loud noise damages the inner-ear receptors and leads to listening to loss, next issues of verbal exchange within the presence of history noise, and, almost certainly, social isolation. there's less public wisdom in regards to the noise publicity that produces merely transitority listening to loss yet that during the long run ends up in listening to difficulties as a result of harm of high-threshold auditory nerve fibers.

Evidence-Based Dementia Practice

The period of healing nihilism in dementia has ended, with the emergence of brokers for symptomatic therapy, those who hold up the process the affliction or hinder the onset of dementia, and new the right way to deal with indicators. With the growth of remedies, there's a transparent probability of being beaten via the amount of knowledge.

Carpal Tunnel Syndrome - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References

It is a 3-in-1 reference e-book. It supplies an entire clinical dictionary masking hundreds and hundreds of phrases and expressions when it comes to carpal tunnel syndrome. It additionally provides huge lists of bibliographic citations. eventually, it presents info to clients on the best way to replace their wisdom utilizing quite a few web assets.

Multiple Sclerosis Therapeutics

This booklet comprehensively reports the present nation of medical trial tools in a number of sclerosis therapy, delivering investigators, sponsors and experts with present wisdom of final result measures and learn designs for disorder and symptom administration. The prestige of the swiftly evolving box of disease-modifying medications is gifted, with emphasis at the such a lot promising treatments at the moment being verified.

Extra resources for Cardiovascular Risk Factor Management in the Prevention of Stroke: Satellite Symposium Held on the Occasion of the 11th European Stroke Conference, ... 2002: Proceedings (CEREBROVASCULAR DISEASES)

Sample text

Eur Neurol 1988;28:227–231. 10 Wolf PA, D’Agostino RB, O’Neal MA, Sytkowski P, Kase CS, Belanger AJ, Kannel WB: Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992;23: 1551–1555. 11 Bronner LL, Kanter DS, Manson JE: Primary prevention of stroke. N Engl J Med 1995;333: 1392–1400. 12 Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992;304:405– 412. Stroke Prevention: A Note to Neurologists 13 Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD: Health outcomes associated with antihypertensive therapies used as first-line agents.

The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ 1996; 313:147. 29 PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041. 30 Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432–1437. 38 31 Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K; SECURE Investigators: Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

The SPARCL trial has enrolled approximately 4,600 patients and results are expected in 2004. The reasons for the benefits of statin therapy in stroke prevention are unclear since, paradoxically, the link between serum cholesterol level and stroke has never been fully established. Furthermore, the positive results of statins trials were mainly obtained in patients with an average or low serum cholesterol level. This suggests nonhyperlipidaemic effects of these drugs, which promote atherosclerotic plaque stability, may also play a role.

Download PDF sample

Rated 4.06 of 5 – based on 34 votes